OGN Organon & Co.
Organon & Co. (OGN) is expected to report earnings on October 30, 2026, before the market open. The consensus earnings estimate is $0.95 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +1.3% since its last earnings release on July 31, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Organon & Co.
Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives.
Sector
Healthcare
Industry
Drug Manufacturers/Other